Deciphera Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCPH and other ETFs, options, and stocks.

About DCPH

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors.

CEO

Steven L. Hoerter

CEOSteven L. Hoerter

Employees

355

Employees355

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2003

Founded2003

Employees

355

Employees355

DCPH Key Statistics

Market cap

1.19B

Market cap1.19B

Price-Earnings ratio

-6.40

Price-Earnings ratio-6.40

Dividend yield

—

Dividend yield—

Average volume

436.25K

Average volume436.25K

High today

$14.69

High today$14.69

Low today

$14.05

Low today$14.05

Open price

$14.17

Open price$14.17

Volume

383.23K

Volume383.23K

52 Week high

$17.73

52 Week high$17.73

52 Week low

$9.90

52 Week low$9.90

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

9.1%

Sell

9.1%